No Data
Hikari Tsushin: Extraordinary Report
Hikari Tsushin To Go Ex-Dividend On March 28th, 2025 With 167 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Hikari Tsushin(9435.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 167 JPY dividend per share. The ex-
Express News | 【Large Shareholding Report】 The Fukutake Educational Foundation reports holding 10.16% of shares in Hikari Communications (9435.JP).
Express News | [Change Report] Yasunari Shigeta reported an increase in Shareholding of Hikaru Communications (9435.JP) to 48.04%.
Individual stock information.
Kei Pharma <4896.T> is under a stop-high buy order. Keio University School of Medicine, which conducts joint research with the company, announced new research findings on regenerative medicine targeting subacute spinal cord injuries, one of the candidates in the development pipeline for regenerative medicine, on the weekend of the 21st. In the clinical study of regenerative medicine using iPS cell-derived neural progenitor cells, improvements were observed in two out of four patients. Saifuse <4892.T> Tokyo Stock Exchange is utilizing Margin Trading.
List of convertible stocks (Part 5) [List of stocks with Parabolic Cigna Corp signals]
○ List of stocks changed to Sell in the market Code Stock Name Closing Price SAR Main Board <9009> Keisei 1425 1583 <9045> Keihan HD 32983475 <9048> Meitetsu 17781820 <9076> Seino HD 22292279 <9273> Koa Shoji HD 704747 <9319> Chuo Warehouse 14401528 <9435> Hikari Communications 3760039220 <947
See the daily top gainer.